Related Experiment Video
Updated: Jun 5, 2025

10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
12.6K
Characterizing changes in executive functions and performance in daily activities after chemotherapy: A pre-post
Khawla Loubani1,2, Debbie Rand3, Abed Agbarya4,5
1Faculty of Health Sciences, Occupational Therapy Department, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Plos One
|December 13, 2024
Summary
Chemotherapy can impair executive functions (EF), affecting daily activities. This study tracked EF changes and their impact on daily performance in cancer patients before and after treatment.
Area of Science:
- Oncology
- Neuroscience
- Rehabilitation
Background:
- Chemotherapy often leads to cognitive impairments, specifically executive function (EF) deficits.
- These EF deficits can negatively impact cancer patients' ability to perform daily activities.
- Understanding these changes is crucial for supportive care.
Purpose of the Study:
- To investigate changes in executive functions (EF) in cancer patients undergoing chemotherapy.
- To assess the impact of chemotherapy-induced EF changes on daily activity performance.
- To explore patient experiences through qualitative data.
Main Methods:
- Convergent parallel mixed-method pre-post experimental design.
- Adult cancer patients (stages I-III, non-CNS malignancy) were studied pre- and post-chemotherapy (12 weeks).
- Assessed daily activity performance (Canadian Occupational Performance Measure), EF, cognition, fatigue, and emotional well-being; qualitative data via open-ended questions.
Main Results:
- Pre-chemotherapy, no significant difficulties in daily activities were reported.
- Post-chemotherapy, executive function impairments became apparent.
- The study identified a clear link between EF deficits and reduced daily activity performance.
Conclusions:
- Integrating quantitative and qualitative data provides a holistic view of cognitive changes.
- Findings highlight the need for interventions to mitigate cognitive decline.
- Effective interventions can help minimize deterioration in daily activities post-chemotherapy.
Related Concept Videos
Cognitive Development During Adulthood
54
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
54
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
224
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
224
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
96
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
96

